Do you suffer from Idiopathic Pulmonary Fibrosis (IPF)?
You aren’t alone.
Although IPF is rare, it still affects approximately 5 million people worldwide.1
We’re looking to see how well an investigational medication works in treating the symptoms of IPF.
Would you like to participate in an investigational study for patients who have Idiopathic Pulmonary Fibrosis (IPF)?
We're inviting you to take part in a study for patients who have IPF to evaluate the effect of the investigational study drug in treating the symptoms of IPF. All study-related visits, tests, care, and study drug will be provided at no cost. In addition, compensation for study-related travel may be provided. Health insurance is not required to participate.
The study will be evaluating the efficacy of an investigational study drug for treating the symptoms of IPF. Volunteers who qualify to take part in the study may receive compensation for their time and travel expenses.
Participants may be eligible to take part in the IPF Studies if you:
- Are over the age of 40
- Have a diagnosis of IPF
About Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis (IPF) is a rare type of lung disease that causes scarring, known as fibrosis, of the tissue surrounding the alveoli (air sacs), in the lungs.
Those who have a family history of IPF or are a smoker have a significantly higher risk of developing Idiopathic Pulmonary Fibrosis. The risk also increases with age.
The way that IPF advances can present differently in each individual case, however, common symptoms may include:
- Shortness of breath
- Dry cough
- Clubbing of the fingers and/or toes
- Unintended weight loss
- Shallow breathing
Over time, complications as a result of IPF may occur, including serious conditions like hypertension and respiratory failure.
Although there are certain medications that may slow the progression of IPF and improve quality of life there is no cure.
The IPF Studies are evaluating an investigational drug for adults with IPF.
Frequently Asked Questions
What is a Clinical Research Study?
A Clinical Research Study (also called a clinical trial) is a medical study that helps answer important questions about an investigational drug or device, such as: does it work, or how effective is it compared to another drug/device?
All medications must be tested in clinical research studies before they can be approved by regulatory authorities for doctors to prescribe to patients. Without people taking part in these studies, we would have no new treatments. The volunteers who participate in clinical research studies play a major role in helping to advance medicine.
What can you expect from the IPF Studies?
The IPF Studies will include various visits to a study clinic in your area and follow up phone calls at designated times.
All study-related care is provided at no cost to you. You do not need health insurance to participate.
Volunteers who take part in the study may receive compensation for their time and travel.
Participation is entirely voluntary. Even if you decide to take part in this study, you can change your mind about participating at any time.
Is there a cost to participate?
There is no cost to participate in the IPF Studies. If you qualify, the investigational drug, study-related tests, assessments, and visits will be provided to you at no cost. You will receive study-related care throughout the study from a team of professional doctors and nurses.
Will I be compensated for time and travel?
Volunteers who take part in the studies may be compensated for their time and travel. Please discuss this with the study team when they contact you.
Sign Up
What happens if I Sign Up? If you think you might like to participate in the Idiopathic Pulmonary Fibrosis Trial or would like more information, please enter your information below so we can see if you may qualify and can contact you about the trial. Keep in mind that participation is entirely voluntary. If you do decide to take part in a trial, you may change your mind about participating at any time.
If you qualify, we will match you to a clinical research site in your area that is seeking participants or notify you if one becomes available. They will contact you to explain more about the trial before you make your decision about participating. You will attend an in-person visit where the trial team will help determine if you qualify and if the trial is right for you.
About the IPF Studies
The IPF Studies will include patients with Idiopathic Pulmonary Fibrosis and will be conducted at various study sites in the USA. All study-related care will be provided by specialty physicians and a dedicated study team.
If you qualify for a study, you will visit a study site in your area throughout the study.
The IPF Studies will be evaluating the effectiveness of an investigational study drug in treating the symptoms of IPF. Volunteers who qualify to take part in the study may receive compensation for time and travel expenses.
Who can take part in the IPF Studies?
Participants may be eligible to take part in the IPF Studies if you:
- Are over the age of 40
- Have a diagnosis of IPF
All study-related care will be provided by a team of experienced doctors and nurses.